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Background: With diminishing costs of next generation sequencing (NGS), whole genome analysis becomes a
standard tool for identifying genetic causes of inherited diseases. Commercial NGS service providers in general not
only provide raw genomic reads, but further deliver SNP calls to their clients. However, the question for the user
arises whether to use the SNP data as is, or process the raw sequencing data further through more sophisticated
SNP calling pipelines with more advanced algorithms.
Results: Here we report a detailed comparison of SNPs called using the popular GATK multiple-sample calling protocol
to SNPs delivered as part of a 40x whole genome sequencing project by Illumina Inc of 171 human genomes of Arab
descent (108 unrelated Qatari genomes, 19 trios, and 2 families with rare diseases) and compare them to variants
provided by the Illumina CASAVA pipeline. GATK multi-sample calling identifies more variants than the CASAVA
pipeline. The additional variants from GATK are robust for Mendelian consistencies but weak in terms of statistical
parameters such as TsTv ratio. However, these additional variants do not make a difference in detecting the causative
variants in the studied phenotype.
Conclusion: Both pipelines, GATK multi-sample calling and Illumina CASAVA single sample calling, have highly similar
performance in SNP calling at the level of putatively causative variants.
Keywords: NGS, GATK, CASAVA, WGS pipeline, Mendelian inheritance, Qatari population, Multi-sample calling,
Genotype calling, Variant, Trios, IlluminaBackground
Numerous NGS pipelines and tools have been developed
in recent years that are valuable to users in the field, but
also create confusion in selecting the desired tool. Some
of the commercial NGS pipelines are CLC genomics
workbench, DNASTAR, CASAVA, Genious, Genomatix
Solutions, GenoMiner, Partek Genomics Suite and so
on. Most of the commercial NGS pipeline tools are tar-
geted to biologists as end-users highlighting easy and* Correspondence: Karsten@suhre.fr
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unless otherwise stated.user friendly interface. Often, these commercial tools be-
come difficult to customize for speed when processing
large number of samples. Alternatively, commercial ven-
dors provide the facility to process and ship the complete
variants sets along with the sequencing of samples. Non-
commercial open source NGS pipelines such as GATK
[1,2], SAMtools [3], SOAP [4,5], SNPAAMapper [6], WEP
[7], Atlas2 [8] are also being used extensively in academia
and many organizations. These open source NGS pipe-
lines are highly customizable but require expertise to set
up optimally. Many studies have been done to evaluate
NGS data analysis pipelines and tools. Bao S. et al. [9]
have evaluated various mapping and assembly software.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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NGS tools at different analytical steps like quality assess-
ment, alignment, variant identification, variant annotation
and visualization. Nielsen et al. [11] have evaluated various
SNP and genotype calling algorithms. Although these
studies have helped tremendously in determining which
tools and pipelines to use, they do not answer the concrete
question of whether to use data provided from a commer-
cial vendor or to put in extra efforts to run additional
well-known open source pipelines. Also, in situations
where we fail to identify a causative variant in the data set
provided by commercial vendors, we may doubt the pipe-
line’s ability to find the variants. Thus, it becomes import-
ant to compare the variant sets provided by commercial
vendors with variants obtained through one of the well-
reputed tools. Several studies have confirmed the GATK
pipeline’s excellent performance in detecting variants. The
GATK pipeline is being used in large projects, such as the
1000 Genomes Project and The Cancer Genome Atlas
[1,12]. However, smaller labs and institutes often rely fully
on commercial vendors for complete sequencing and ana-
lysis services. Illumina Inc. is a leader in providing NGS
services. Illumina uses the CASAVA and ISSAC pipelines
for variant detection. Illumina has reported comparison
among ISAAC, CASAVA and GATK pipelines; mostly for
the speed of completing the pipeline [13]. However, an in-
dependent detailed comparison between the Illumina and
GATK pipeline using multi-sample calling algorithm in
larger cohorts is necessary. Here we compared variant sets
supplied by the Illumina CASAVA pipeline and the well-
known GATK pipelines in great detail on concrete study
cases and discuss the differences from a user’s perspective.
In general, genotype calling errors by the variant callers
are associated with Mendelian violation when the caller is
unaware of family structure [14]. In this study, both
GATK and CASAVA are unaware of family pedigree and
therefore Mendelian inheritance is examined in familial
samples for the genotypes of discordant variants by the
pipelines. As an additional independent quality control we
use genotyping array data from the Illumina OMNI 2.5
array. We present an evaluation of the CASAVA and the
GATK pipelines for three different data sets: 108 unrelated
Qatari genomes, 19 trios from studies on obesity and dia-




Illumina SNP calls were based on the CASAVA
−1.9.0a1_110909 pipeline. SNPs and the genotype from
the CASAVA pipeline were called for each sample indi-
vidually. We created a pass quality subset of these variants
by keeping the variant for which Filter column in VCF file
has value “PASS” and removing all other variants. Thus,the first set without any quality filter will be called
CASAVA ALL and the quality filtered set will be called
CASAVA PASS in this paper. In many cases, we have
compared the pipelines for a group of samples. In
these cases, we merged these SNPs from the CASAVA
pipeline using vcftools [15]. Similarly, we created merged
VCF for quality filtered (PASS quality) from the CASAVA
pipeline by merging all the PASS quality SNPs based on
quality column annotation (Genotype quality >20) in all
single sample VCF files.
GATK best practice pipeline
In our in-house pipeline, we used Bowtie2 [16] to align
the sequencing reads against the human reference gen-
ome build 37. We also used other necessary tools like
SAMtools [3], Novosort and Picard [17] to process and
format alignment files before processing them with GATK.
We implemented the best practices of GATK pipeline to
call SNPs and Indels. We have used GATK 2.4 version and
GATK-UnifiedGenotyper as SNP caller in this study.
We have used multi-sample variant calling by GATK-
UnifiedGenotyper. The reason of using multi-sample
calling is to distinguish non-variant genotypes between
homozygous reference genotype and missing genotype
in cohort analysis. With single sample calling genotype
called only for variants we can’t be sure if the non-
variants have missing genotype or same as reference.
Also, big projects like 1000 genomes have preferred
multi-sample calling over single sample calling [18].
We used GATK-UnifiedGenotyper instead of GATK-
HaplotypeCaller, a similar or better variant caller by
GATK, in this study because of similar accuracy in
calling SNPs and computational feasibility to run for
large number of samples. For more than 100 samples,
according to GATK website, GATK-UnifiedGenotyper
is advised over GATK-HaplotypeCaller. The real ad-
vantage of Haplotypecaller over UnifiedGenotyper is in
calling Indels but in this paper we are focusing on
SNPs only. Next, similar to the CASAVA pipeline, we
created two variant sets, GATK ALL (without any quality
filter) and GATK PASS (by keeping the variant for which
Filter column in VCF file has value “PASS” and removing
all other variants) from our in-house GATK pipeline. The
variants found by GATK pipeline were recalibrated using
GATK walker VariantScoreRecalibrater. The input true
sites in creating the model were SNPs from dbSNP
Human build 132 [19], genotyping OMNI array calls of
1000 genomes project and Hapmap SNP calls for estimat-
ing the probability that SNPs are true genetic variants ra-
ther than a sequencing or data processing artifact. The
call sets were partitioned into quality trenches and are
shown in the plot below. We took the variants until we
found 99% of known variants (truth sensitivity) in the
GATK PASS variant set.
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Human genotyping array data is from Illumina Human-
Omni2.5-8 platform. This array has about 2.37 million tag
SNPs from 1000 genomes pilot project with MAF ≥2.5%.
Illumina Inc. supplied genotypes for all the samples from
HumanOmni2.5-8 by performing Illumina Infinium LCG
assay and thereupon calling the genotypes using their propri-
ety software called GenomeStudio. They provide genotype
for each of these probes with GenCall scores. Illumina
recommends a GenCall score cut-off of 0.15 for their
infinium assay based products [20]. This recommended
GenCall score cut-off of 0.15 was used to test the con-
cordance with the GATK and CASAVA pipelines.
Evaluation data sets
1. 108 unrelated individuals from QatarFig
Indi
IndiGenotypes from HumanOmni2.5-8 array and Whole
Genome Sequencing (WGS) data analysis from
CASAVA and GATK pipeline are compared for
these 108 unrelated individuals from Qatar. Whole
Genome Sequencing was done by Illumina Hiseq
2500 sequencer with the average coverage of 37.99
(see Additional file 1). Phenotypes of theseure 1 19 trios in family pedigree. Rectangular boxes drawn in the famil
vidual in black are obese. Star marked individuals were not sequenced. In
vidual with no color are non-obese individuals.individuals are either diabetic or normal individuals.
Illumina CASAVA pipeline called variants using a
single sample (genome) at a time while we used
GATK multi-sample calling.
2. 19 trios (Father, Mother, Offspring)
These 19 trios are selected from another cohort of
64 individuals with 11 different families. Whole
Genome Sequencing was done by Illumina Hiseq
2500 sequencer with the average coverage of 39.50
(Additional file 1). Variants from the GATK pipeline
were called for all the 64 individuals together by
multi-sample calling using the UnfiedGenoytper and
variant sets for trios were filtered using SelectVariants
walker. The pedigree structures for families from
which trios are selected are shown in Figure 1.
3. Two clinical case studies of monogenic disorders
In the first family (Figure 2A), both affected children
are present with hypoplasia of cerebellum as a
disease phenotype. The other three members
(Father, mother and aunt) are unaffected. The
second family (Figure 2B) comprises two affected
children with abnormal pain sensation and two
unaffected children. Whole Genome Sequencing was
done by Illumina Hiseq 2500 sequencer with they pedigree indicate the trios taken for pipelines comparison analysis.
dividuals greyed in the pedigrees had unknown phenotype.
Figure 2 Pedigrees of the families with children affected with monogenic homozygous recessive disease. Star marked Individuals were
not sequenced. Individuals in grey in the pedigrees had unknown phenotype. Individuals with no color are unaffected. Individuals in black color
are affected with hypoplasia of cerebellum in A, and with abnormal pain sensation in B.
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for second family (Additional file 1). In the pipeline
comparison result for these two families, GATK calls
were made by multi-sample calling of all members
of the family whereas CASAVA calls were from
single sample calling.For all three evaluation data sets, although Illumina sup-
plied annotated VCF files, we annotated both Illumina
and GATK VCF files using SnpEff [21] and AnnTools [22]
to provide a uniform annotation for comparison between
pipelines.
Results
The summarized comparison results between the CASAVA
and GATK pipeline are presented in Table 1. Both
CASAVA and GATK have very high similarity to OmniAr-
ray genotypes. However, while comparing all variants from
NGS, GATK identifies a higher number of variants than
CASAVA. The robustness of these additional variants are
analyzed and discussed below in the results presented for
comparison between the pipelines for various data sets.
Comparison of NGS pipelines with genotyping array
The Illumina Omni 2.5 platform can detect genotypes at
2.37 million SNP loci in the human genome. In every
single individual about 30% of these 2.37 million SNPs
were present either in a heterozygous or a homozygous
for the non-reference variant state. Illumina only reports
genotypes for such variants in the VCF files. Reference
allele homozygous calls are not differentiated from non-
call. We therefore compare the pipeline only on SNPs
that are reported in the VCF files. Both pipelines have
very high concordance (~99%) with genotyping array
data (Table 1). GATK pipeline has a higher number of
non-reference SNPs compared to CASAVA, but CASAVAhas slightly higher genotyping matches (99.67%) compared
to GATK (98.33%). For quality passed variants (CASAVA
PASS, GATK PASS) both pipelines have approximately
the same concordance with Illumina Genotyping OmniAr-
ray data (Table 1 and Additional file 2). False positives and
false negatives in Table 1 are calculated assuming Illumina
OMNI 2.5 genotype data to be correct. GATK has lot more
false positive compared to CASAVA before PASS filter and
the opposite after PASS filter. To our surprise, TsTv ratios
of these false positives are not very far from ideal TsTv ratio
of 2.0-2.1. Furthermore, TsTv ratio of false positive by
GATK is better, closer to 2, than the TsTv ratio of false
positive by CASAVA in both before and PASS filter. More-
over, the TsTv ratio of common false positive is near to 2
suggesting these small numbers of common false positive
by both pipelines could be false negative in OMNI 2.5
genotype array data.
Pipeline comparison in unrelated individuals
Venn diagram in Figure 3 shows the comparison be-
tween CASAVA and GATK pipeline for the combined
variants of all 108 unrelated individuals. For the unfiltered
variants set in Figure 3A, GATK ALL and CASAVA
ALL have an approximately equal number of SNPs
(24.01 million for GATK and 23.99 million for CASAVA)
and an equal number of unique SNPs (2.4 million for
GATK and 2.39 million in CASAVA). However, if we look
at the individual sample from GATK and CASAVA in
Figure 4E, we find GATK has many more SNP calls
than CASAVA (4.33 million by GATK and 4.02 million
by CASAVA). This discrepancy, similar number of var-
iants by pipelines at population level but different at
sample level, can be explained by exploring shared and
unique variants across the samples (Figure 5). The
number of shared variants among 108 individuals iden-
tified by GATK is lot more than in CASAVA for both
Table 1 Summary of GATK and CASAVA comparison
Data sets CASAVA GATK Common
Variant count TsTv ratio Variant count TsTv ratio Variant count TsTv ratio
Omni Array Genotyping Data
108 unrelated
(per sample)
All SNP by pipelines 708,089 ± 4,516 3.56 ± 0.003 715,033 ± 4,551 3.53 ± 0.003 706,378 ± 4502 3.57 ± 0.003
GT Matched SNP 705,749 ± 4468 3.58 ± 0.003 703,608 ± 4479 3.59 ± 0.003 698,910 ± 4437 3.60 ± 0.003
Ref or missing by
pipeline
1661347 ± 4538 1654613 ± 4573 1649566 ± 4567
False positive 988 ± 20 1.46 ± 0.020 6320 ± 112 1.61 ± 0.039 489 ± 13 1.92 ± 0.031
False negative 23283 ± 90 22076 ± 58 20550 ± 59
PASS SNP by pipelines 707,128 ± 4506 3.57 ± 0.003 696,960 ± 4480 3.60 ± 0.003 695,589 ± 4456 3.60 ± 0.003
GT Matched SNP 705,106 ± 4459 3.58 ± 0.003 693,135 ± 4434 3.63 ± 0.003 689,330 ± 4394 3.63 ± 0.003
Ref or missing by
pipeline
1662325 ± 4528 1672894 ± 4501 1657868 ± 4533
False positive 810 ± 17 1.33 ± 0.019 277 ± 20 2.23 ± 0.054 229 ± 10 2.12 ± 0.054




All 4,025,625 ± 44,102 2.02 ± 0.001 4,331,336 ± 45,896 1.86 ± 0.002 3,792,293 ± 43,122 2.07 ± 0.000
PASS 3,894,810 ± 43,388 2.04 ± 0.001 3,438,203 ± 41205 2.13 ± 0.001 3,401,091 ± 40317 2.15 ± 0.001
19 trios ( per trio) ALL 5,235,184 ± 47,790 2.01 ± 0.001 7,003,439 ± 56,488 1.88 ± 0.003 4,945,042 ± 46,650 2.06 ± 0.002
PASS 4,786,871 ± 47,564 2.07 ± 0.002 5,125,002 ± 48,717 2.13 ± 0.001 4,320,414 ± 43,062 2.14 ± 0.001
Family 1 ALL 6,082,624 2.00 6,337,108 1.88 5,635,183 2.04
PASS 5,438,393 2.07 5,004,048 2.12 4,898,126 2.13
Family 2 ALL 5,192,891 1.99 5,459,725 1.84 4,752,193 2.03
PASS 4,526,291 2.07 4,205,995 2.12 4,104,343 2.13
Comparison between the pipelines have been done for unfiltered sets (CASAVA ALL, GATK ALL), and for quality filtered sets (CASAVA PASS, GATK PASS).
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The distribution of number of unique variants among
108 individuals identified by GATK and CASAVA are
overlapping in great extant and thus are very similar
(Figure 5c and Figure 5d). Also, we can explain the dis-
crepancy by pipelines at population and sample level
by looking at the pipeline specific calls (GATK ONLYFigure 3 Venn diagrams comparing combined variants of All108 Qata
and CASAVA ALL variants sets showing intersection and unique variants se
intersection and unique variants sets.and CASAVA ONLY calls). Theoretically, CASAVA
ONLY calls should be very different across the 108
samples and GATK only calls should be similar across
108 samples to justify the observed discrepancy. When
we checked the GATK ONLY 2.4 million SNPs of com-
bined variants set (Figure 3A), we found that around
56.6% (1.29 million) were present in more than 5 outri genomes by GATK and CASAVA pipelines. A) Between GATK ALL
ts. B) Between GATK PASS and CASAVA PASS variants sets showing
Figure 4 Individual genome comparison between GATK and CASAVA pipeline in 108 unrelated Qatari individuals. A, C, and E show
comparison for unfiltered sets (CASAVA ALL, GATK ALL). B, D, and F show comparison for quality filtered sets (CASAVA PASS, GATK PASS). A and
B show boxplots of 108 transition-transversion (TsTv) ratios for pipeline’s variants sets (CASAVA, GATK) along with pipeline specific (CASAVA ONLY,
GATK ONLY). C and D show boxplots of 108 het-hom ratios for pipeline’s variants sets (CASAVA, GATK) along with pipeline specific (CASAVA ONLY,
GATK ONLY). E and F show barplot of average variant counts for 108 individuals with error at the top of each bar.
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combined variants (Figure 3A), only 18.8% (0.45 million)
were present in more than 5 out of 108 samples. The higher
percentage of consensus call across the sample in GATK
ONLY SNPs compared to CASAVA ONLY SNPs indicates
the effects of multi-sampling calling using the GATK pipe-
line. We hypothesize that this effect is desired since the sam-
ples are from the same population. In other words, in order
to have confidence in the SNPs that are non-agreeing across
the pipelines, the variant calls should have agreement across
the samples, provided that the samples originate from same
population. However, the variants identified by only one
pipeline (GATK ONLY SNPs or CASAVA ONLY SNPs)
have lower TsTv ratio compared to variants that are com-
mon to both pipeline (Figure 4A and Figure 4B). TsTv ratio
for GATK ONLY SNPs before pass filter in Figure 4A is very
low (1.096 ± 0.003). Similarly, TsTv ratio of CASVA ONLSNPs in Figure 4B is low (1.485 ± 0.001). The lower TsTv ra-
tio of pipeline specific variants indicates the presence of false
positives. Furthermore, Het/Hom ratio of GATK ONLY sub-
set after GATK PASS filter is very high, as shown in
Figure 4D, indicates that GATK calls more false posi-
tive heterozygous calls than homozygous false positive
calls. In general, the explanation of lower TsTv for both
before and after PASS filter should be similar. The more
number of pipeline specific variants has more false posi-
tives. In addition to the pipeline specific variant count, the
lower quality variants could be reason of of very low Tstv
ratio for GATK ONLY in Figure 4A compared to TsTv ra-
tio of GATK ONLY subset in Figure 4B. However, before
pass filter the number of combined set of variants for
GATK ONLY (2.4 million) is similar to CASAVA ONLY
(2.39 million) and, therefore, should not have drastically






















Figure 5 Shared and unique variants by GATK and CASAVA in 108 unrelated Qatari individuals. A shows density plot of unique variants
of 108 unrelated Qatari individuals in GATK ALL, GATK PASS, CASAVA ALL, and CASAVA PASS variant sets. B shows density plot of shared variants
of 108 unrelated Qatari individuals in GATK ALL, GATK PASS, CASAVA ALL, and CASAVA PASS variant sets.
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compared to CASAVA ONLY and intuitively we would be
expecting better TsTv for GATK ONLY compared to
CASAVA ONLY. The opposite behavior of TsTv can thus
be attributed to GATK multi-sample calling which might
be placing doubtful SNP in samples at particular locus if it
one or more samples have confirmed SNP at that locus.
This suggests that multi-sample calling has the advantage
of calling more variants but at the cost of more false posi-
tives. The other possible explanation of lower TsTv ratio
of pipeline specific variants could be non-universal nature
of TsTv ratio [23]. However, we tested this by random
sampling the 2.4 million variants 10 times and computed
TsTv ratio. We found TsTv ratio of these randomly sampled
variant to be 2.051 ± 0.001. This excludes non-universal na-
ture of TsTv ratio as possible explanation. Thus, lower TsTv
for pipeline specific (GATK ONLY and CASAVA ONLY)
subset is indication of false positives. The non-agreeing
SNPs between the pipelines can also be analyzed in a family
structure to see the Mendelian violation, which we did by
looking at 19 trios (Father, Mother, and Offspring) and 2
families having homozygous recessive diseases.
Pipeline differences after PASS filter at per sample
level (Figure 4F) is apposite to before PASS filter (Figure 4E)
i.e. the number of SNPs per sample in GATK call set is
lower than in CASAVA. However, at population level GATK
called more SNPs in both before and after PASS filter
(Figure 3A and Figure 3B). It is important to see how
PASS filter changed the allele frequency distribution in
GATK and CASAVA. Minor Allele Frequency (MAF)
distribution plot shown in Additional file 3 and vari-
ants frequency distribution shown in Additional file 4
to see the effect of PASS filter for both GATK andCASAVA. In Additional file 3, we can see that PASS
filter removes low frequency with high MAF and, there-
fore, we see higher frequency for low MAF. In Additional
file 4, we can see the distributions of GATK before and
PASS filtering is far apart while the distribution of
CASAVA before and PASS filtering has some overlap.
This shows that there are many low quality variants
from each of the 108 unrelated samples identified by
GATK. This also explains the reason of higher false
positives and lower TsTv ratio for of GATK compared
to CASAVA before PASS filter.
Pipelines comparison in trios
The CASAVA and GATK pipelines were compared for 19
trios from the Qatari population by taking combined vari-
ants sets of each trio separately (Figure 6 and Additional
file 5). On average GATK ALL have 7 million variants in
any trio compared to 5.25 million variants in CASAVA
ALL (Figure 6). The large difference between the GATK
ALL and CASAVA ALL variant sets in any trio can be at-
tributed to GATK multi-sample calling, but this gives rise
to the question about the qualities of these extra variants.
Both pipelines have approximately equal percentage of
variants having Mendelian violation (3.40% for CASAVA
ALL and 3.47% for GATK ALL (Figure 6C). Assuming
Mendelian violation as a criterion to judge confidence in
variants, CASAVA pipeline missed those extra 1.75 million
variants present in GATK ALL, which were comparable in
quality. However, the lower TsTv ratio of 1.01 for Mendelian
violated GATK ALL variants compared to TsTv ratio of
1.47 for Mendelian violated CASAVA ALL variants
(Figure 6A) creates doubt about these extra 1.75 million
variants of GATK ALL. The difference between number
CASAVA
GATK
CASAVA ALL,GATK ALL CASAVA PASS, GATK PASS
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Figure 6 GATK and CASAVA comparison in 19 trios. A and C show comparison for unfiltered sets (CASAVA ALL, GATK ALL). B and D show
comparison for quality filtered sets (CASAVA PASS, GATK PASS). A and B shows boxplots of 19 transition-transversion ratios for pipeline’s variants
sets (Total_TsTv) along with TsTv of varaints with Mendelian violations. C and D shows beanplots of 19 trios total and Mendelian violated variant sets.
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GATK and CASAVA pipelines is diminished for quality-
filtered sets (CASAVA PASS and GATK PASS). It’s im-
portant to estimate false positive rate for the decision of
applying the PASS filter or not. Since we do not have
genotyping array data for trios, we are confined to assess
the pipelines performance based on Mendelian violation
and TsTv ratio. We can assume the variant set confirmed
by both pipelines to be robust to provide us the rough es-
timate of the Fraction of Mendelian violation (FMV) in
each trio by the pipeline. Using this fraction we thus com-
puted the Expected number of Mendelian violation in var-
iants subset (EMV) which didn’t pass the PASS filter (NOT
PASS) in the pipelines. We then found the actual number
of variants with Mendelian violation (OMV) in all the vari-
ants in NOT PASS subset (TNP). We then calculated the
false positive fraction in the NOT PASS subset by (OMV –
EMV)/TNP. This way we found mean false positive percent
of 11.15% for GATK NOT PASS subset and 22.90% for
CASAVA NOT PASS subset in 19 trios. The detailed
numbers are shown in Additional file 6. The false positive
percent in CASAVA NOT PASS is higher than GATK
NOT PASS in trios that is in contrast to false positive per-
cent by pipelines in 108 unrelated individuals when com-
puted using Genotyping OMNI array data. It suggests that
GATK multi-sample calling algorithm works better in re-
lated individuals compared to unrelated individuals. In
order to check the real difference at a functional level, we
evaluated the pipeline performance in real case of findingthe causative homozygous recessive variant in two dis-
eased families.
Pipelines comparison for calling variants in monogenic
homozygous recessive diseased families
We analyzed two different families with affected children.
In Family 1, affected children were diagnosed with the
phenotype of hypoplasia of cerebellum which is mono-
genic homozygous recessive disease [24-28]. In Family 2,
affected children were diagnosed with abnormal pain sen-
sation, which is also monogenic homozygous recessive
disease [29-33]. The number of variants between pipelines
and between quality filter sets follows the similar pattern
of what we saw above in the comparison between the
pipelines in trios. However, in these cases, the difference
in Mendelian violation between the pipelines is strongly
pronounced. The difference is more between CASAVA
ALL and GATK ALL variants set and the detail of this
shown in Table 2 and Table 3 for Diseased Family 1 and
Diseased Family 2 correspondingly. Since, CASAVA PASS
and GATK PASS variants sets have lot of similarity; the
details of number of variants for various categories are
shown in Additional file 7 and Additional file 8 for Dis-
eased Family 1 and Disease Family 2 correspondingly.
Diseased family 1
The CASAVA pipeline has 4.78% (290985 out of 6082624)
of variants with Mendelian violation in the CASAVA ALL
set and 1.23% (66903 out of 5438393) of variants with
Table 2 GATK and CASAVA comparison in diseased Family 1
Pipelines CASAVA all GATK all
HRC HRC
Total Total HRC by CASAVA butnot by GATK Total Total
HRC by GATK but
not by CASAVA
Total number of variant 6082624 61497 409 6337108 63774 1349
TsTv Ratio 2.00 2.09 1.88 1.88 2.03 1.07
Mendelian Violation 290985 0 0 187920 0 0
In dbSNP 5562308 60769 268 5609116 62277 643
In interGenic 3682138 35416 257 3790849 36884 846
In CDS 65785 650 2 64452 638 2
In ‘3 UTR 77701 849 16 82211 853 11
In ‘5 UTR 18552 240 0 20093 246 4
In Intronic 4113210 47220 218 4412928 48805 818
In Non_coding_intronic 214239 1826 26 217104 1839 40
In Exonic 57842 580 1 56762 579 3
In Non_coding_exonic 16356 110 0 15196 106 0
In Putative Promoter Region 12780 135 0 15517 141 1
Non-Synonymous Coding 19080 159 1 18299 161 2
Common Variant 5395888 60389 205 5905677 62830 1335
Common Homozygougs Minor Variant
in 1000genome
4777175 56874 104 4792920 57620 194
Common Homozygougs Minor Variant
in Q108
4727231 57643 142 4915274 60169 1293
Common Het (>5%) Variant in 1000genome 4479609 56407 99 4494483 57151 189
Common Het(>5) Variant in Q108 4895168 59296 63 5422841 62027 1332
Comparison between the pipelines have been done for unfiltered sets (CASAVA ALL, GATK ALL), and subset of variants fulfilling the criteria of Homozygous
Recessive Conditions (HRC).
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http://www.biomedcentral.com/1756-0500/7/747Mendelian violation in the CASAVA PASS set. In contrast,
GATK has only 2.96% (187920 out of 6337108) of variants
with Mendelian violation in the GATK ALL set and 0.14%
(7122 out of 5004048) of variants with Mendelian viola-
tion in the GATK PASS set (Table 2 and Additional file 7).
Because both children are affected by the hypoplasia of
cerebellum, and the parents and aunt are unaffected, the
causative variant should be a homozygous variant [34].
We further investigated the pipeline performance to find
the homozygous recessive variants. In this paper, we use
the term Homozygous Recessive Condition (HRC) for any
particular variant position in a family when all three of the
following conditions are met: 1) all affected off-springs are
homozygous, 2) all affected off-springs have the same geno-
type and their genotype is different than normal individuals
in the family, and 3) all affected off-springs follow Mendelian
inheritance (e.g. Father GT = A/C, Mother GT = A/C,
Affected Child 1 GT =C/C, Affected Child 2 GT=C/C).
Both CASAVA and GATK pipelines have approximately a
similar number of HRC variants (Table 2). They also have
a similar number of region specific or known variants like
exonic, CDS, 3’UTR, 5’UTR, intronic, non-synonymous
coding, 1000genome and so on. Furthermore, the pipelineshave a similar number of commonly known variants such
as those in 1000 genomes, and Q108 (108 unrelated indi-
viduals from Qatar). After filtering the known variants, we
tried to map these variants to known genes for the
phenotype in the literature. We could not map the set
of possible causative variants to known genes in this case.
Therefore, we tried another real case of homozygous reces-
sive disease with a pair of normal and affected siblings.
Diseased family 2
This family is different in structure because of the pres-
ence of unaffected siblings (Figure 2B), which gives extra
power to evaluate the pipeline because of the inherent
validation about the variants, e.g. evaluating homozygous
recessive variants identified by both the pipelines but
mismatched in genotypes according to Mendelian inher-
itance in affected and unaffected separately. We have
presented a detailed comparison of the pipeline perfor-
mances for this family in Table 3. The additional param-
eters to judge the pipelines in Table 3, as compared to
the previous case in Table 2, are due to the additional
two normal siblings in this case. Exclusively determined
HRC variants are divided into two sets of variants for
Table 3 GATK and CASAVA comparison in diseased Family 2
Pipelines CASAVA all GATK all
HRC HRC
HRC by CASAVA but not
by GATK
HRC by GATK but not by
CASAVA








Total number of variant 5192891 29522 912 781 131 5459725 30653 2043 1499 544
TsTv Ratio 1.99 2.04 1.30 By CASAVA 1.21 2.05 1.84 2.00 1.29 By CASAVA 1.37 1.09
By GATK 1.23 By GATK 1.37
Mendelian Violation 416915 3 1 By CASAVA 0 1 265402 8 8 By CASAVA 1010 5
By GATK 244 By GATK 3
Mendelian Violation in affected 279336 0 0 By CASAVA 0 0 189043 0 0 By CASAVA 929 0
By GATK 211 By GATK 0
Mendelian Violation in unaffected 267367 3 1 By CASAVA 0 1 182659 8 8 By CASAVA 257 5
By GATK 82 By GATK 3
In dbSNP 4717672 28409 738 656 82 4754687 29129 1458 1243 215
In interGenic 3152905 18780 602 516 86 3266794 19527 1349 999 350
In CDS 54766 339 6 3 3 53607 359 26 11 15
In ‘3 UTR 64961 476 4 4 0 69395 483 11 8 3
In ‘5 UTR 15087 81 0 0 0 16635 92 11 10 1
In Intronic 3484737 19668 487 427 60 3797577 20562 1381 976 405
In Non_coding_intronic 180421 931 38 29 9 182875 972 79 57 22
In Exonic 48608 284 6 3 3 47577 292 14 7 7
In Non_coding_exonic 13960 82 8 8 0 12525 82 8 7 1
In Putative Promoter Region 10932 56 0 0 0 13801 66 10 10 0
Non-Synonymous Coding 16299 97 4 3 1 15429 100 7 3 4
Common Variant (1000genome+Q108) 4693812 28034 784 728 56 5224846 29186 1936 1418 518
Homozygougs Minor Variant in
1000genome
4089468 26162 396 364 32 4098301 26562 796 726 70
Homozygougs Minor Variant in Q108 4283672 26479 663 628 35 4469485 27677 1861 1357 504
Het (>5%) Variant in 1000genome 3888895 25824 386 354 32 3897416 26225 787 717 70
Het(>5) Variant in Q108 4355312 27616 686 674 12 4900523 28852 1922 1408 514
Non-Synonymous rare Pain related 5 1 0 0 0 5 1 0 0 0
Pain genes mapped to
Non-Synonymous rare
variants
4 1 0 0 0 4 1 0 0 0
Comparison between the pipelines have been done for unfiltered sets (CASAVA ALL, GATK ALL), and subset of variants fulfilling the criteria of Homozygous Recessive
Conditions (HRC).
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http://www.biomedcentral.com/1756-0500/7/747analyzing pipeline performance: 1) HRC variant by Pipeline1
and not by Pipeline2 and having mismatch in genotype calls
between the pipelines, and 2) HRC variant by Pipeline1 and
none from Pipeline2 for all five individuals.
In the first set of variants (Table 3, Column “GT mis-
match by GATK” and “GT mismatch by CASAVA”), in
which only one pipeline meets HRC and the pipelines have
mismatch in genotype calls, the pipeline not meeting HRC
can either have Mendelian inheritance or Mendelian viola-
tion. The cases, where both the pipelines have Mendelian
inheritance and only one pipeline meets HRC, are difficultto evaluate in terms of pipeline performance. Example vari-
ant position genotypes in this family are as follows:
Pipeline 1 Genotypes (Mendelian Inheritance and HRC):
Father GT = A/C, Mother GT = A/C, Unaffected
Child1 GT = A/C, Unaffected Child2 GT = A/C,
Affected Child1 GT = C/C, Affected Child1 GT = C/C;
Pipeline2 Genotypes (Mendelian Inheritance but no
HRC): Father GT = A/A, Mother GT = A/C, Unaffected
Child1 GT = A/A, Unaffected Child2 GT = A/A,
Affected Child1 GT = A/C, Affected Child2 GT = A/C.
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http://www.biomedcentral.com/1756-0500/7/747The cases where one pipeline has both HRC and Men-
delian inheritance and other pipeline has neither could
be a strong indication that the second pipeline calls are
wrong in these variants. Example variant position geno-
types in this family are as follows:
Pipeline 1 Genotypes (Mendelian Inheritance and HRC):
Father GT = A/C, Mother GT = A/C, Unaffected
Child1 GT = A/C, Unaffected Child2 GT = A/C,
Affected Child1 GT = C/C, Affected Child1 GT = C/C;
Pipeline2 Genotypes (No HRC due to Mendelian
violation in affected off-springs): Father GT = A/A,
Mother GT = A/A, Unaffected Child1 GT = A/A,
Unaffected Child2 GT =A/A, Affected Child1 GT =C/C,
Affected Child1 GT =C/C.
In Table 2, we can see in the CASAVA ALL and GATK
ALL sets that out of 1499 exclusively determined HRC
variants by GATK, 929(62%) had both Mendelian viola-
tions and different genotypes by the CASAVA pipeline. In
contrast, out of 781 exclusively determined HRC variants
by CASAVA, only 244 (31%) have both Mendelian viola-
tions and different genotypes. Therefore, we can say that
for exclusively determined HRC where there is mismatch
between the genotype calls between the pipelines, the
GATK pipeline is more robust than the CASAVA pipeline,
if we compare all the variants without any quality filter.
We also examined Mendelian violation in another set
of exclusively determined HRC variants by one pipeline
where there were no variants in any member of the fam-
ily by the second pipeline (Table 3, Column “Absent in
GATK” and “Absent in CASAVA”). Both CASAVA and
GATK have almost no Mendelian violation in these
cases.
Table 3 also shows many categories to compare CASAVA
and GATK. CASAVA identifies slightly more number of
Non-synonymous variants compared to GATK. However,
GATK has higher percentage of Non-synonymous variants
as HRC variants compared to CASAVA. About one hun-
dred of these Non-Synonymous variants of both the pipe-
lines are linked to 60 pain related genes by literature
identified using SnpEff [21] and AnnTools [22]. After ex-
cluding the common variants (variants present in homozy-
gous state in either 1000 genomes or 108 unrelated Qatari
individuals, and variant present in heterozygous state with
MAF >5%) from these non-synonymous variants, there
were 5 variants left by both the pipelines (Non-synonymous
pain related rare variant in Table 3). From both pipelines,
out of these 5 variants only one was HRC variant and most
probably the causative variant.
Discussion
We found excellent performances of both GATK and
CASAVA pipelines in matching the genotype calls whenmatching with Illumina OmniArray genotype calls. How-
ever, we saw differences in the number of variants called
by each pipeline in unfiltered variant sets (CASAVA ALL,
GATK ALL) and generally GATK identifies more variants
because of its multi-sample calling algorithm. Most of
these additional variants are of low quality but not bad in
terms of Mendelian inheritance. CASAVA pipeline, in
most of the cases, have TsTv ratio closer to 2 compared to
GATK. Since both CASAVA and GATK pipeline were un-
aware of the pedigree structure while calling the geno-
types, in conflicting or discordant genotypes by the
pipelines, Mendelian inheritance is a good criterion to
judge the confidence of variants for familial samples.
In general, GATK pipeline called less Mendelian viola-
tion for all different sets. Notably, PASS filter in GATK
pipeline drastically minimizes Mendelian Violation, from
2.4% in GATK ALL to 0.14% in GATK PASS in disease
family 1 and from 4.86% in GATK ALL to 0.19% in GATK
PASS in disease family 2. However, in CASAVA pipeline
PASS filter does not reduce Mendelian violation signifi-
cantly, from 4.78% in CASAVA ALL to 1.23% in CASAVA
PASS in disease family 1 and from 8.03% in CASAVA
ALL to 1.87% in CASAVA PASS in disease family 2. By
assuming Mendelian violation to be inversely correlated
to pipeline performance in cases of genotype mismatch
and where the other pipeline satisfies HRC, GATK multi-
sample calling performs better than CASAVA single sam-
ple calling for these cases. However, we didn’t find any
significant difference in the ability of these pipelines to
identify causative variants in this abnormal pain per-
ception family. We also found extremely low Mendel-
ian violation in exclusively determined homozygous
recessive condition for which variants were not called
in any family member by the other pipeline, which sug-
gests robustness of both GATK and CASAVA pipelines in
finding the functional variants. This broad level agreement
between the pipelines suggests that normally we can avoid
calling variants again using more sophisticated algorithm
except for specific scientific goals. One of such specific
scientific goals could be finding de novo mutation in sam-
ples where comprehensiveness of variants are desired and
can be obtained by taking combining the variant sets from
the pipelines with tolerated false positives. Also, if the
cohort sample size is large and scientific goal is based
on the phase SNPs, it is desirable to use more sophisti-
cated SNP calling platform such as GATK multiple-
sample calling.
On other note, the results presented here should hold
for newer version of GATK as well. In furtherance, we
did the sensitivity analysis (see Additional file 9) for 10
different versions of GATK released in last one and half
year for our diseased family 2 data set. The relative
standard deviation of variant counts of different versions
of GATK for before and PASS filter sets are only 0.89%
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http://www.biomedcentral.com/1756-0500/7/747and 2.02% respectively while the difference between
GATK and CASAVA presented in this paper using
GATK v2.4 are around 4.9% and 7.6% before and PASS
filter set respectively. Similarly, the relative standard de-
viation of TsTv of different versions of GATK for before
and PASS filter sets are and only 0.58% and 0.59% re-
spectively while the difference between GATK and CASAVA
presented in this paper using GATK v2.4 are around 8.2%
and 2.4% before and PASS filter set respectively. Thus, the
different version of GATK have very little effect on the num-
ber of variants identified and thus doesn’t change the results
and conclusion drawn in this paper using GATK v2.4.
We have used 3 different type of data set (108 unre-
lated, 19 trios, and 2 diseased families) to cover some of
the various possible data sets. We have found difference
in results for related and unrelated individuals. In gen-
eral, the pipeline comparison results should hold for
most of the possible data set with some limitations. We
have only tested for sequences coming from Illumina
platform that helps in fair comparison of the pipeline
but the result might deviate for sequence reads from
some other platform. Also, we have not tested for com-
plex diseases like cancer where somatic mutation is
frequent.Conclusion
High quality SNP calls delivered by commercial NGS se-
quencing projects in general show concordance with
array genotypes and Mendelian inheritance. Application
of more sophisticated SNP calling platforms, i.e. using
GATK multiple-sample calling, may be helpful in valid-
ating and expanding the number of possible candidates,
especially in related individuals, but may not provide
additional candidates for monogenic disorders. In gen-
eral, it is futile effort of calling variants again using open
source alternative when commercial vendors had already
supplied variants sets. However, in cases of related indi-
viduals where commercial providers lack the information
of relatedness because of confidentially involved, one
should try multiple-sample calling to expand variants
conforming Mendelian inheritance.Additional files
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